Citation 5683

MATSUDA,H: ASAO,Y: NAKAMURA,S: HAMAO,M: SUGIMOTO,S: HONGO,M: PONGPIRIYADACHA,Y: YOSHIKAWA,M:. (2009). ANTIDIABETOGENIC CONSTITUENTS FROM THE THAI TRADITIONAL MEDICINE COTYLELOBIUM MELANOXYLON. 57(5)

Citation Details

Title	ANTIDIABETOGENIC CONSTITUENTS FROM THE THAI TRADITIONAL MEDICINE COTYLELOBIUM MELANOXYLON
Authors	MATSUDA,H: ASAO,Y: NAKAMURA,S: HAMAO,M: SUGIMOTO,S: HONGO,M: PONGPIRIYADACHA,Y: YOSHIKAWA,M:
Year	2009
Volume	57
Issue	5

Summary

Year: 2009

Journal: Unknown

Organisms and Their Experiments (2)

Cotylelobium melanoxylon (DIPTEROCARPACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	HYPOGLYCEMIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
2	HYPOTRIGLYCERIDEMIA ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
3	GASTRIC EMPTYING TIME INCREASED	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
4	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	MELANOXYLON A	None
6	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED	LYONIRESINOL ,(+):VINIFERIN,EPSILON: (+):AMPELOPSIN F,(+):AMPELOPSIN F,ISO: (+):VATICANOL G	None
7	HYPOGLYCEMIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	VATICANOL G	ACTIVE
8	HYPOTRIGLYCERIDEMIA ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	VATICANOL G	ACTIVE
9	GASTRIC EMPTYING TIME INCREASED	PHARMACOLOGY OF COMPOUND - IN VIVO	VATICANOL G	ACTIVE
10	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	VATICANOL G	ACTIVE

Cotylelobium melanoxylon (DIPTEROCARPACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	HYPOGLYCEMIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
2	HYPOTRIGLYCERIDEMIA ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
3	GASTRIC EMPTYING TIME INCREASED	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
4	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	MELANOXYLON B	None
6	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED	VINIFERIN,EPSILON: (+):VINIFERIN,EPSILON: CIS:VATICANOL AVATICANOL GVATICANOL E	None
7	HYPOGLYCEMIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	MELANOXYLON BVINIFERIN,EPSILON: CIS:VATICANOL AVATICANOL GVATICANOL E	ACTIVE
8	HYPOTRIGLYCERIDEMIA ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	MELANOXYLON BVINIFERIN,EPSILON: CIS:VATICANOL AVATICANOL GVATICANOL E	ACTIVE
9	GASTRIC EMPTYING TIME INCREASED	PHARMACOLOGY OF COMPOUND - IN VIVO	MELANOXYLON BVINIFERIN,EPSILON: CIS:VATICANOL AVATICANOL GVATICANOL E	ACTIVE
10	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MELANOXYLON BVINIFERIN,EPSILON: CIS:VATICANOL AVATICANOL GVATICANOL E	ACTIVE

Show SPARQL Queries (1)